Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve The Standalone and Consolidated Unaudited Financial Results for the Second quarter and half year ended September 30, 2024, along with limited review report to be issued by the Statutory Auditors and to consider other business matters, if any